1228542-64-0 Usage
General Description
The chemical "(S)-2-(tert-butoxycarbonylamino)-2-(3-fluorophenyl)acetic acid" is a compound with the molecular formula C14H18FNO4. It is a chiral amino acid derivative used in the synthesis of pharmaceuticals and other organic compounds. (S)-2-(tert-butoxycarbonylaMino)-2-(3-fluorophenyl)acetic acid contains a tert-butoxycarbonyl (Boc) protecting group and a fluorophenyl group attached to the acetic acid moiety. The chiral center in the molecule gives rise to two enantiomers, (S)- and (R)-2-(tert-butoxycarbonylamino)-2-(3-fluorophenyl)acetic acid, with potentially different biological activities. This chemical has potential applications in drug development and research.
Check Digit Verification of cas no
The CAS Registry Mumber 1228542-64-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,5,4 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1228542-64:
(9*1)+(8*2)+(7*2)+(6*8)+(5*5)+(4*4)+(3*2)+(2*6)+(1*4)=150
150 % 10 = 0
So 1228542-64-0 is a valid CAS Registry Number.
1228542-64-0Relevant articles and documents
Site selective substitution of carbamate and carbamoyl protected benzylamines
Katsoulos,Schlosser
, p. 6263 - 6264 (1993)
Methoxy and fluoro substituted benzylamines can be metalated optionally at the position adjacent to the nitrogen bearing side chain or adjacent to the hetero substituent as a function of the acyl type protective group.
HETEROARYL DERIVATIVES
-
Paragraph 0502; 0503; 0504; 0505, (2015/06/17)
Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
PHENYLETHYLPYRIDINE DERIVATIVES AS PDE4-INHIBITORS
-
Page/Page column 69; 70, (2014/06/24)
The invention relates to novel compounds which are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
